The effectivness of strontium 89 in palliative therapy of painful prostate cancer bone metastases;Ocena skuteczności leczenia bólu zwia̧zanego z przerzutami raka prostaty do kości z użyciem izotopu strontu ( 89Sr)

Ortopedia Traumatologia Rehabilitacja

Volumn 5, Issue 3, 2003, Pages 364-368

  Ba̧czyk, Maciej ^a,d   Milecki, Piotr ^b   Ba̧czyk, Ewa ^c   Sowiński, Jerzy ^c  

^a AM   (Poland)

^b GREATER POLAND CANCER CENTRE   (Poland)

^c Klinik Opieki Paliatywnej   (Poland)

^d POZNAN UNIVERSITY OF MEDICAL SCIENCES   (Poland)

Author keywords

Bone metastases; Pain; Radioisotope therapy; Strontium 89

Indexed keywords

ANALGESIC AGENT; STRONTIUM 89;

ADULT; AGED; ANALGESIA; ARTICLE; BONE METASTASIS; BONE PAIN; BONE SCINTISCANNING; CANCER PALLIATIVE THERAPY; CANCER RADIOTHERAPY; HUMAN; MAJOR CLINICAL STUDY; MALE; MOTOR ACTIVITY; OSTEOBLAST; OSTEOLYSIS; PROSTATE CANCER; SPINAL CORD COMPRESSION; TREATMENT OUTCOME;

EID: 18144442664     PISSN: 15093492     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (9)

1. Lewington VJ.: Cancer therapy using bone-seeking isotopes. Phys Med Biol 1996: 41: 2027-2042
2. Robinson RG et al: Strontium 89: Treatment results and kinetics in patients with painful metastatic prostate and breast cancer in bone. Radiographics 1989; 9 (2): 271-278
3. Silberstein EB.: Advances in our understanding of the treatment of painful metastases. J Nucl Med 2000; 41: 655-657
4. Porter AT, McEvan AJ et al: Results of a randomised Phase III trial to evaluate the efficacy of strontium 89 adjuvant to local field external beam irradiation in the management of endocrine resistant metastatic prostate cancer. Int J Radiation Oncol Biol Phys 1993; 25 (5): 805-813
5. Quilty PM, Kirk D, Bolger JJ et al: A comparison of the palliative effects of strontium 89 and external beam radiotherapy in metastatic prostate cancer. Radiotherapy and Oncology 1994; 31; 33-40
6. Oxford Textbook of Palliative Medicine Oxford University Press 1994
7. Kraeber-Bodere F., Campion L et al.: Treatment of bone metastases of prostate cancer with strontium-89 chloride: efficacy in relation to the degree of bone involvement. Eur J Nucl Med 2000: 27: 1487-1493
8. Dafermou A., Colamussi P. et al: A multicentre observational study of radionuclide therapy in patients with painful bone metastases of prostate cancer. Eur J Nucl Med 2001: 28: 788-798
9. O'Donoghue JA., Bardies M., Wheldon TE.: Relationships between tumor size and curability for uniformly targeted therapy with beta-emitting radionuclides. J Nucl Med 1995; 36: 1902-1909.